Results of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy after early failure of adjuvant systemic chemotherapy

Journal of Surgical Oncology

Volumn 103, Issue 5, 2011, Pages 431-434

  Klaver, Yvonne L B ^a   De Hingh, Ignace H J T ^a   Boot, Henk ^b   Verwaal, Victor J ^b  

^a CATHARINA HOSPITAL   (Netherlands)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

Colorectal cancer; Patient selection; Peritoneal carcinomatosis

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CARCINOMATOUS PERITONITIS; CLINICAL ARTICLE; COLORECTAL TUMOR; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DRUG FEVER; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; MALE; OVERALL SURVIVAL; PATIENT CODING; PATIENT SELECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEX RATIO; SURVIVAL RATE; SYSTEMIC THERAPY; TREATMENT FAILURE; TREATMENT OUTCOME; TUMOR RECURRENCE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; LEUCOVORIN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; ORGANOPLATINUM COMPOUNDS; PERITONEAL NEOPLASMS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 79952583663     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.21836     Document Type: Article

References (27)

1. Bloemendaal ALA, Verwaal VJ, van Ruth S, et al.: Conventional surgery and systemic chemotherapy for peritoneal carcinomatosis of colorectal origin:Aprospective study. Eur J Surg 2005;31:1145-1151.
2. Folprecht G, Kohne CH, Lutz MP: Systemic chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Cancer Treat Res 2007;134:425-440.
3. Sugarbaker PH, Graves T, DeBruijn EA, et al.: Early postoperative intraperitoneal chemotherapy as an adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: Pharmacological studies. Cancer Res 1990;50:5790-5794. (Pubitemid 20331378)
4. Sugarbaker PH: Peritonectomy procedures. Ann Surg 1995;221:29-42.
5. Elias D, Delperro JR, Sideris L, et al.: Treatment of peritoneal carcinomatosis from colorectal cancer: Impact of complete cytoreductive surgery and difficulties in conducting randomized trials. Ann Surg Oncol 2004;11:518-521. (Pubitemid 40486734)
6. Glehen O, Cotte E, Schreiber V, et al.: Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg 2004;91:747-754. (Pubitemid 38746144)
7. Glehen O, Kwiatkowski F, Sugarbaker PH, et al.: Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: A multi-institutional study. J Clin Oncol 2004;22:3284-3292. (Pubitemid 41103684)
8. Kecmanovic DM, Pavlov MJ, Ceranic MS, et al.: Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy. Eur J Surg Oncol 2005;31:147-152. (Pubitemid 40214749)
9. Mahteme H, Hansson J, Berglund A, et al.: Improved survival in patients with peritoneal metastases from colorectal cancer: A preliminary study. Br J Cancer 2004;90:403-407. (Pubitemid 38250636)
10. Pilati P, Mocellin S, Rossi CR, et al.: Cytoreductive surgery combined with hyperthermic intraperitoneal intraoperative chemotherapy for peritoneal carcinomatosis arising from colon adenocarcinoma. Ann Surg Oncol 2003;10:508-513. (Pubitemid 40486913)
11. Piso P, Dahlke MH, Ghali N, et al.: Multimodality treatment of peritoneal carcinomatosis from colorectal cancer: First results of a new German centre for peritoneal surface malignancies. Int J Colorectal Dis 2007;22:1295-1300. (Pubitemid 47456713)
12. Schneebaum S, Arnold MW, Staubus A, et al.: Intraperitoneal hyperthermic perfusion with mitomycin C for colorectal cancer with peritoneal metastases. Ann Surg Oncol 1996;3:44-50. (Pubitemid 126729488)
13. Shen P, Hawksworth J, Lovato J, et al.: Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol 2004;11:178-186. (Pubitemid 40486793)
14. Verwaal VJ, Bruin S, Boot H, et al.: 8-year follow-up of randomized trial: Cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy in patients with peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2008;15:2426-2432.
15. Yan TD, Sim J, Morris DL: Selection of patients with colorectal peritoneal carcinomatosis for cytoreductive surgery and perioperative intraperitoneal chemotherapy. Ann Surg Oncol 2007;14:1807-1817. (Pubitemid 46870939)
16. Elias D, Lefevre JH, Chevalier J, et al.: Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol 2009;27:681-685.
17. Verwaal VJ, van Ruth S, de Bree E, et al.: Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737-3743. (Pubitemid 46606227)
18. Sugarbaker PH, Schellinx ME, Chang D, et al.: Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996;20:585-591.
19. Cunningham D, Humblet Y, Siena S, et al.: Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351:337-345. (Pubitemid 38944402)
20. de Gramont A, Figer A, Seymour M, et al.: Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer. J Clin Oncol 2000;18:2938-2947. (Pubitemid 30644117)
21. Hurwitz HI, Fehrenbacher L, Hainsworth JD, et al.: Bevacizumab in combination with fluorouracil and leucovorin: An active regimen for first-line metastatic colorectal cancer. J Clin Oncol 2005;23:3502-3508.
22. Saltz LB, Cox JV, Blanke C, et al.: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 2000;343:905-914.
23. Katz MH, Barone RM: The rationale of perioperative intraperitoneal chemotherapy in the treatment of peritoneal surface malignancies. Surg Oncol Clin N Am 2003;12:673-688. (Pubitemid 36920092)
24. Schott A, Vogel I, Krueger U, et al.: Isolated tumor cells are frequently detectable in the peritoneal cavity of gastric and colorectal cancer patients and serve as a new prognostic marker. Ann Surg 1998;227:372-379. (Pubitemid 28131018)
25. Sugarbaker PH: Carcinomatosis - Is cure an option? J Clin Oncol 2003;21:762-764.
26. Del Rio M, Molina F, Bascoul-Mollevi C, et al.: Gene expression signature in advanced colorectal cancer patients select drugs and response for the use of leucovorin, fluorouracil, and irinotecan. J Clin Oncol 2007;25:773-780. (Pubitemid 350002876)
27. Sticca RP, Dach BW: Rationale for hyperthermia with intraoperative intraperitoneal chemotherapy agents. Surg Oncol Clin N Am 2003;12:689-701. (Pubitemid 36920093)